SFI
JNCE

Susquehanna Fundamental Investments’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Susquehanna Fundamental Investments’s Portfolio JNCE Stock Details JNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q1 		$242K Buy
35,698
+9,500
+36% +$64.4K ﹤0.01% 1312
2021
Q4 		$219K Sell
26,198
-3,405
-12% -$28.5K 0.01% 1215
2021
Q3 		$220K Sell
29,603
-4,191
-12% -$31.1K ﹤0.01% 1514
2021
Q2 		$230K Buy
+33,794
New +$230K ﹤0.01% 1445